IRCT20140519017756N40
Completed
Phase 1
Therapeutic effects of fluticasone nasal spray on clinical symptoms and serum IgE of patients with allergic sinonasal polyposis: A clinical trial
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mashhad University of Medical Sciences
- Enrollment
- 34
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •grade 2 nasal polyposis or lower grades
- •positive skin prick test
- •signed informed consent
- •age more than 18 years old
Exclusion Criteria
- •use of nasal or systemic corticosteroid during the past month
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the Treatment of Seasonal allergiesEUCTR2015-004885-27-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd936
Active, not recruiting
Not Applicable
A 6-month study to assess the safety and benefit of inhaled fluticasone propionate/salmeterol combination compared with inhaled fluticasone propionate in the treatment of adolescents (12 years and over) and adults with asthma.AsthmaMedDRA version: 17.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2011-001644-29-CZGlaxoSmithKline Research & Development Limited11,664
Completed
Phase 2
Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute RhinosinusitisSinusitis, AcuteNCT01018030GlaxoSmithKline741
Active, not recruiting
Phase 1
Efficacy of Fluticasone Propionate associated With Salmeterol underwent allogeneic hematopoietic stem cell transplantatioBronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT)..Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-003010-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)243
Active, not recruiting
Phase 1
A Comparison of Fluticasone Furoate Nasal Spray (FFNS) versus OralFexofenadine in the Treatment of Seasonal Allergies.Seasonal Allergic RhinitisTherapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2015-004873-34-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd680